Feline Multiple Myeloma
Also known as: Plasma Cell Myeloma
⚠ Emergency Warning Signs
Significant bleeding, severe lethargy, or signs of acute kidney dysfunction warrant prompt veterinary evaluation.
Overview
A cancer of plasma cells (a type of immune cell normally responsible for antibody production), genuinely rare in cats but recognized as a distinct condition — can affect multiple body systems given plasma cells' normal presence throughout the body, notably including effects on bone, kidney function, and blood composition.
Symptoms
- Lethargy
- Weight loss
- Bone pain/lameness
- Bleeding tendencies
Causes
The specific underlying cause of this cancer isn't well established, similar to many cancers; it represents an abnormal, cancerous proliferation of plasma cells rather than having a clearly identified external trigger. A cancer of plasma cells (a type of white blood cell involved in antibody production) within the bone marrow, multiple myeloma is genuinely rare in cats, and can cause a range of effects including bone pain/lesions, kidney problems (from abnormal proteins these cancerous cells produce), and anemia.
Risk Factors
No strongly established specific risk factor given the rarity of this condition in cats; older age is a general risk factor for cancer broadly.
Transmission
Not applicable — not an infectious or contagious condition.
Incubation Period
Not applicable.
Disease Stages & Progression
Develops gradually as abnormal plasma cells proliferate, potentially affecting bone marrow function, producing abnormal antibody proteins that can affect kidney function and blood viscosity, and in some cases causing bone lesions.
Early Warning Signs
Often non-specific initially — lethargy, decreased appetite, and sometimes lameness or bone pain if bone involvement is present.
Advanced Symptoms
More significant lethargy, weight loss, signs of kidney dysfunction if the abnormal proteins this cancer produces affect kidney function, bleeding tendencies (from effects on normal blood clotting), and bone pain or fractures if significant bone involvement has occurred.
Diagnostic Methods
A combination of the characteristic blood protein abnormality, bone marrow examination showing abnormal plasma cell proliferation, and imaging findings (bone lesions, if present) supports diagnosis. Diagnosis typically requires a combination of bloodwork showing abnormal protein patterns, bone marrow examination showing excess plasma cells, and sometimes imaging looking for characteristic bone lesions — the combination of these findings, rather than any single test alone, establishes the diagnosis.
Veterinary Examination Process
General assessment for lethargy, weight loss, and any bone pain or lameness, alongside broader physical examination.
Recommended Lab Tests
Blood protein electrophoresis (identifying the characteristic abnormal protein spike), bone marrow aspirate/biopsy, kidney function panel, and complete blood count.
Diagnostic Imaging
X-rays may show characteristic bone lesions in affected areas if bone involvement is present; abdominal imaging assesses for organ involvement.
Blood Test Indicators
An abnormal spike in a specific type of protein (called a monoclonal gammopathy) on blood protein testing is a hallmark finding; kidney function tests, and a complete blood count assessing for anemia or other blood cell abnormalities.
Biopsy / Histopathology
Bone marrow examination showing abnormal plasma cell infiltration is central to diagnosis.
Differential Diagnoses
Other causes of abnormal blood protein levels, other bone marrow disorders, and other cancers — the specific combination of findings (protein abnormality, bone marrow changes, and any bone lesions) helps confirm this specific diagnosis.
Home Monitoring Guidance
Not a substitute for veterinary evaluation and monitoring given this condition's complexity and potential for multi-system effects.
Veterinary Treatment Options
Chemotherapy is the primary treatment approach, aiming to control the abnormal plasma cell proliferation; supportive care addresses specific complications as they arise (kidney support, management of bleeding tendencies, pain management for bone involvement). Chemotherapy is the standard treatment approach, aiming to control the abnormal plasma cell population and manage associated complications like kidney effects; given this cancer's rarity in cats, treatment protocols are often adapted from more established human or canine myeloma treatment approaches.
Surgery Requirements
Not typically a primary treatment approach for this systemic condition, though might be relevant for a specific complication like a pathological fracture.
Recovery Timeline
Not applicable in the sense of a fixed recovery arc — this is generally a condition managed on an ongoing basis with chemotherapy and supportive care rather than one with a defined endpoint.
Possible Complications
Kidney dysfunction from the abnormal proteins this cancer produces, bleeding tendencies from effects on normal clotting function, bone lesions or fractures, and general progression of the underlying cancer if not adequately controlled with treatment.
Long-Term Management
Ongoing chemotherapy and monitoring, along with supportive management of specific complications as they arise.
Prevention
No established prevention given the not-well-understood cause of this cancer.
Vaccination Availability
Not applicable.
Prognosis
Variable and generally guarded given this cancer's systemic nature, though chemotherapy can help control disease and manage symptoms for a meaningful period in many cases.
References
Veterinary Cancer Society; American College of Veterinary Internal Medicine (ACVIM).
Medications Used
- Chemotherapy
- Supportive medications addressing specific complications (kidney support, pain management)
Estimated Treatment Cost by Country
| Country | Estimated Cost Range | Notes |
|---|---|---|
| IN | 20,000–90,000 INR | |
| US | 2,000–8,500 USD | |
| UK | 1,800–7,500 GBP | |
| AU | 2,500–9,500 AUD | |
| JP | 300,000–1,000,000 JPY | |
| DE | 2,000–8,000 EUR | |
| BR | 4,000–16,000 BRL |
Frequently Asked Questions
What is the abnormal protein my vet mentioned finding in my cat's blood?
This refers to a specific antibody-related protein produced in abnormally large amounts by the cancerous plasma cells — this distinctive finding (called a monoclonal gammopathy) is actually one of the more useful and characteristic clues pointing toward this specific diagnosis, distinguishing it from many other conditions.
Can this cancer be cured?
It's generally managed as a chronic condition with chemotherapy aiming to control the disease and its complications, rather than being considered curable in the way some other conditions might be — the goal is typically extending good-quality life through ongoing management rather than a one-time curative treatment.